To our knowledge, this possibility has not been investigated in prostate cancer cells, although the effects of [R]-methanandamide, the metabolically stable analogue of anandamide, upon the viability of PC-3 cells are mediated by CB2 rather than TRPV1 receptors [53]. This evidence concerns the gene CNR2 and prostate carcinoma.